Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

40.72
+0.25340.63%
Post-market: 40.720.00000.00%19:30 EDT
Volume:9K
Turnover:379.04K
Market Cap:1.05B
PE:- -
High:40.89
Open:40.73
Low:40.57
Close:40.47
52wk High:42.87
52wk Low:27.30
Shares:25.75M
Float Shares:25.75M
Volume Ratio:0.34
T/O Rate:0.04%
Dividend:0.43
Dividend Rate:1.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS
·
Yesterday

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS
·
Yesterday

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Yesterday

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Yesterday

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Reuters
·
Yesterday

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Yesterday

Johnson & Johnson reports PAPILLON study meets primary endpoint

TIPRANKS
·
Yesterday

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Yesterday

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Yesterday

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Yesterday

Johnson & Johnson Says Lung Cancer Drug Combination Extends Median Survival to Over 34 Months

MT Newswires Live
·
Yesterday

J&J Shares up 1.2% Premarket After Report Co's Orthopedics Unit Draws Apollo Interest in Potential $20 Bln Deal

THOMSON REUTERS
·
Yesterday

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Yesterday

Dow Jones Top Company Headlines at 1 am ET: Biggest AI Rivals Agree They Need to Slow it Down | Amazon ...

Dow Jones
·
Yesterday

J&J - Rybrevant Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Nsclc

THOMSON REUTERS
·
Yesterday

Dow Jones Top Company Headlines at 9 PM ET: Amazon Pauses Operations with 21 Air After Miami Crash | Pfizer ...

Dow Jones
·
Yesterday

Johnson & Johnson in Advanced Talks to Sell Orthopaedics Unit to Apollo in Potential $20B Deal

Deep News
·
Sep 13

Snowflake, Applied Materials, Dell, Zoom, Bristol-Myers Insider Shock

TIPRANKS
·
Sep 12

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Apollo in Advanced Talks to Acquire Johnson \u0026 Johnson's Orthopedics Unit in Deal Valued Near $20B

Stock News
·
Sep 12